Training Core

培训核心

基本信息

  • 批准号:
    10684156
  • 负责人:
  • 金额:
    $ 15.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-15 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract The techniques of CRISPR/Cas9-mediated genomic editing and the ability to generate induced pluripotent stem cells (iPSCs) from a sample of a patient’s blood have placed medicine on the brink of a revolution in our ability to treat, and perhaps even cure, a broad range of genome-based diseases. Over the past four years the Wellstone Muscular Dystrophy Cooperative Research Center at the University of Texas Southwestern Medical Center (now the UTSW Wellstone MDSRC) has made tremendous strides toward the translation of this technology to benefit patients with Duchenne muscular dystrophy, and ultimately, other forms of muscular dystrophy. The mission of the Training Core has been just as impactful as it is essential to train a new generation of clinicians, physician-scientists, and basic scientists who are able to apply these evolving technologies in the service of muscular dystrophy patients and their community. The objective of the training core is to enhance the educational environment of the Wellstone network in order to recruit, train, and maintain the next generation of transformative investigators focused on addressing the challenges of muscular dystrophy. Our approach focuses on five elements: (Aim 1) To enhance the training environment of the UTSW Wellstone Center and promote trainee career advancement, (Aim 2) To recruit new trainees to muscular dystrophy research, (Aim 3) To mentor trainees in the process of obtaining funding support for the next step in their careers, (Aim 4) To organize research meetings involving Wellstone trainees, and (Aim 5) To organize training activities that benefit the overall muscular dystrophy research community. To accomplish these goals, we’ve built on the very successful program developed over the past four years of funding, that has both complemented and leveraged the strengths of existing training programs here at UTSW.
项目总结/摘要 CRISPR/Cas9介导的基因组编辑的技术和产生诱导的表达的能力, 来自患者血液样本的多能干细胞(iPSC)已经将医学置于一个危险的边缘。 这将是我们治疗甚至治愈一系列基于基因组的疾病的能力的革命。超过 在过去的四年里,威尔士大学的威尔斯通肌肉营养不良合作研究中心 得克萨斯州西南医学中心(现在的UTSW韦尔斯通MDSRC)已经取得了巨大的进步, 致力于将这项技术转化为有益于杜氏肌营养不良症患者的技术, 最终导致其他形式的肌肉萎缩症。训练核心的使命 影响力,因为它对培养新一代临床医生,医生科学家和基础科学家至关重要 他们能够将这些不断发展的技术应用于肌肉萎缩症患者的服务, 社区培训核心的目标是改善井石的教育环境 网络,以招募,培训和保持下一代变革调查员的重点 应对肌营养不良症的挑战。我们的方法侧重于五个要素:(目标1) 改善UTSW Wellstone中心的培训环境,促进学员的职业发展 促进,(目标2)招募新学员进行肌营养不良症研究,(目标3)指导 (目标4)为学员的下一步职业生涯提供资金支持, (目标5)组织培训活动, 整个肌肉萎缩症研究界。为了实现这些目标,我们建立在 在过去四年的资助中,成功开发了一个项目, 充分利用了UTSW现有培训项目的优势。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Beverly A Rothermel其他文献

Beverly A Rothermel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Beverly A Rothermel', 18)}}的其他基金

Elevated mitochondrial fusion and function in Down syndrome - Revision - 2
唐氏综合症中线粒体融合和功能升高 - 修订版 - 2
  • 批准号:
    10645484
  • 财政年份:
    2022
  • 资助金额:
    $ 15.96万
  • 项目类别:
Elevated mitochondrial fusion and function in Down syndrome
唐氏综合症患者线粒体融合和功能增强
  • 批准号:
    9894475
  • 财政年份:
    2019
  • 资助金额:
    $ 15.96万
  • 项目类别:
Training Core
培训核心
  • 批准号:
    10473538
  • 财政年份:
    2015
  • 资助金额:
    $ 15.96万
  • 项目类别:
Training Core
培训核心
  • 批准号:
    10261405
  • 财政年份:
    2015
  • 资助金额:
    $ 15.96万
  • 项目类别:
Calcineurin's role in circadian regulation of cardiac function and remodeling
钙调神经磷酸酶在心脏功能和重塑的昼夜节律调节中的作用
  • 批准号:
    7925750
  • 财政年份:
    2009
  • 资助金额:
    $ 15.96万
  • 项目类别:
Calcineurin's role in circadian regulation of cardiac function and remodeling
钙调神经磷酸酶在心脏功能和重塑的昼夜节律调节中的作用
  • 批准号:
    8103108
  • 财政年份:
    2009
  • 资助金额:
    $ 15.96万
  • 项目类别:
Calcineurin's role in circadian regulation of cardiac function and remodeling
钙调神经磷酸酶在心脏功能和重塑的昼夜节律调节中的作用
  • 批准号:
    8301643
  • 财政年份:
    2009
  • 资助金额:
    $ 15.96万
  • 项目类别:
Modulating Calcineurin Signaling Pathways in Muscle
调节肌肉中的钙调神经磷酸酶信号通路
  • 批准号:
    7822352
  • 财政年份:
    2009
  • 资助金额:
    $ 15.96万
  • 项目类别:
Calcineurin's role in circadian regulation of cardiac function and remodeling
钙调神经磷酸酶在心脏功能和重塑的昼夜节律调节中的作用
  • 批准号:
    7755621
  • 财政年份:
    2009
  • 资助金额:
    $ 15.96万
  • 项目类别:
Modulating Calcineurin Signaling Pathways in Muscle
调节肌肉中的钙调神经磷酸酶信号通路
  • 批准号:
    7878736
  • 财政年份:
    2002
  • 资助金额:
    $ 15.96万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 15.96万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 15.96万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了